Aromatase Inhibitor Host Factors Study

NCT01669343 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

121

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: Letrozole

Sponsor

Samuel Lunenfeld Research Institute, Mount Sinai Hospital